| Model Number |
TRULIANT PS CEM FEM PS CEM LEFT SZ 3.5 |
| Medical Device Problem Code |
Loosening of Implant Not Related to Bone-Ingrowth (4002)
|
| Health Effect - Clinical Codes |
Failure of Implant (1924); Pain (1994)
|
| Date of Event |
10/19/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
As reported, approximately four years post initial left side tka, the 42 y/o male complained of pain.Patient had loose femur.Patient was not revised to exactech devices due to recall surgeon used competitor.There was no breakage of a device.There was no surgical delay/prolongation.Patient was last known to be in stable condition following the event.Photos received.The device is not available for evaluation due to recall hospital will not release.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information, including the product investigation, will be submitted within 30 days of receipt.
|
| |
|
Additional Manufacturer Narrative
|
|
(h3) the revision reported was likely the result of an insufficient bond between the femoral component and the bone, patient-related conditions, or a combination of the two, which led to aseptic (non-infected) femoral loosening.However, this cannot be confirmed as the devices were not available for evaluation.The most probable root cause associated with the reported event of ¿loosening - femoral¿ is associated with weakened integration of the femoral component at the bone-implant interface due to loss of fibrous and/or bony tissue and leading to compromised anchorage of the device.
|
| |
|
Additional Manufacturer Narrative
|
|
The revision reported was likely the result of an insufficient bond between the femoral component and the bone, patient-related conditions, or a combination of the two, which led to aseptic (non-infected) femoral loosening.However, this cannot be confirmed as the devices were not available for evaluation.The most probable root cause associated with the reported event of ¿loosening - femoral¿ is associated with weakened integration of the femoral component at the bone-implant interface due to loss of fibrous and/or bony tissue and leading to compromised anchorage of the device.
|
| |
|
Additional Manufacturer Narrative
|
|
This follow-up report is being submitted to relay additional and/or corrected information.The following sections were updated/corrected: h6.Mdr section codes updated/corrected: b, c, d, e, g.The revision reported was likely the result of an insufficient bond between the femoral component and bone interface which led to aseptic (non-infected loosening).A secondary finding is damage along the articulating surface of the patella.However, the loosening and nature of the patellar damage (in-vivo or removal) cannot be confirmed because the devices were not returned for evaluation and pre-revision radiographs were not provided.If any further information is obtained that would change or alter any information provided, a supplemental report will be filed accordingly.
|
| |
|
Search Alerts/Recalls
|